Острые инфекционно-воспалительные заболевания дыхательных путей у детей. Возможности терапии

1. Клинические рекомендации «Пневмония (Внебольничная)» (ID: 714_2) 2025. Министерство здравоохранения РФ.

2. Бакрадзе М.Д., Кустова О.В., Лукина О.Ф. и др. Болезни органов дыхания у детей. Руководство для врачей, 8-е издание, дополненное. Москва: Status Praesens, 2025. 600 с.

3. Yun K.W., Wallihan R., Juergensen A., et al. Community-Acquired Pneumonia in Children: Myths and Facts. Am J Perinatol. 2019;36(S 02):S54-S57. https://dx.doi.org/10.1055/s-0039-1691801

4. Katz S.E., Williams D.J. Pediatric Community-Acquired Pneumonia in the United States: Changing Epidemiology, Diagnostic and Therapeutic Challenges, and Areas for Future Research. Infect Dis Clin North Am. 2018;32(1):47-63. https://dx.doi.org/10.1016/j.idc.2017.11.002

5. Lukianenko N., Kens O., Nurgaliyeva Z., et al. Finding a molecular genetic marker for the incidence of recurrent episodes of acute obstructive bronchitis in children. J Med Life. 2021;14(5):695–99. https://dx.doi.org/10.25122/jml-2021-0052

6. Wopker P.M., Schwermer M., Sommer S., et al. Complementary and alternative medicine in the treatment of acute bronchitis in children: A systematic review. Complement Ther Med. 2020;49:102217. https://dx.doi.org/10.1016/j.ctim.2019.102217

7. Клинические рекомендации «Бронхит» (ID: 381_3) 2024. Министерство здравоохранения РФ.

8. Petat H., Schuers M., Le Bas F., et al. Characterizing acute respiratory infections in primary care for better management of viral infections. NPJ Prim Care Respir Med. 2025;35(1):28. https://dx.doi.org/10.1038/s41533-025-00434-w

9. Fang Y., Lei M., Zhang L., et al. Epidemiological, clinical, and molecular analysis of human adenovirus infections in hospitalized children with acute respiratory infections in Tianjin, China. Front Cell Infect Microbiol. 2025;15:1600990. https://dx.doi.org/10.3389/fcimb.2025.1600990

10. Huang J., Wang Q., Zhuo Z., Yuan L. Clinical characteristics and epidemiological analysis of respiratory adenovirus infection in hospitalized children. BMC Infect Dis. 2025;25(1):1776. https://dx.doi.org/10.1186/s12879-025-11705-9

11. Teoh Z., Toepfer A.P., Rohlfs C., et al. Viral Detection in Children <5 Years with Bronchiolitis, Pneumonia, and Croup, New Vaccine Surveillance Network, 2017-2023. J Pediatric Infect Dis Soc. 2025;14(11):piaf096. https://dx.doi.org/10.1093/jpids/piaf096

12. Savino F., Montanari P., Dini M., et al. Peripheral blood and nasal swabs Type I and III IFNs signature in RSV positive infant with bronchiolitis. J Immunol Methods. 2025;543:113918. https://dx.doi.org/10.1016/j.jim.2025.113918

13. Akkuş A., Kiliç A.O., Ercan F., et al. Evaluation of Intestinal Permeability in Children Diagnosed With Bronchiolitis in Pediatric Emergency Department: A Cross-Sectional Study. Pediatr Pulmonol. 2025;60(6):e71171. https://dx.doi.org/10.1002/ppul.71171

14. Michelow I.C., Olsen K., Lozano J., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2004;113(4):701–707. https://dx.doi.org/10.1542/peds.113.4.701

15. Jain S., Williams D.J., Arnold S.R., et al; CDC EPIC Study Team. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835–845. https://dx.doi.org/10.1056/NEJMoa1405870

16. Jansen R.R., Wieringa J., Koekkoek S.M., et al. Frequent detection of respiratory viruses without symptoms: toward defining clinically relevant cutoff values. J Clin Microbiol. 2011;49(7):2631–2636. https://dx.doi.org/10.1128/JCM.02094-10

17. Shi J., Han S., Zhang Y., et al. Respiratory bacterial and viral pathogen spectrum among influenza-positive and influenza-negative patients. BMC Infect Dis. 2025;25(1):866. https://dx.doi.org/10.1186/s12879-025-11232-7

18. Abdullahi O., Nyiro J., Lewa P., et al. The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya. Pediatr Infect Dis J. 2008;27(1):59–64. https://dx.doi.org/10.1097/INF.0b013e31814da70c

19. Esposito S., Patria M.F., Tagliabue C., et al. CAP in children. In: Chalmers J, Pletz M, Aliberti S, eds. Community-Acquired Pneumonia. European Respiratory Monograph, Vol. 63. Sheffield, European Respiratory Society. 2014. P. 130–139.

20. Koehler U., Hildebrandt O., Fischer P., et al. Time course of nocturnal cough and wheezing in children with acute bronchitis monitored by lung sound analysis. Eur J Pediatr. 2019;178(9):1385-1394. https://dx.doi.org/10.1007/s00431-019-03426-4

21. Ralston S.L., Lieberthal A.S., Meissner H.C., et al.; American Academy of Pediatrics. Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis. Pediatrics. 2014;134(5):e1474–e1502.

22. Zhao X., Lv J., Wu M., Wu Q. Clinical characteristics and risk factors for Mycoplasma pneumoniae pneumonia in children. Front Pediatr. 2024;12:1438631. https://dx.doi.org/10.3389/fped.2024.1438631

23. Akashi Y., Hayashi D., Suzuki H., et al. Clinical features and seasonal variations in the prevalence of macrolide-resistant Mycoplasma pneumoniae. J Gen Fam Med. 2018;19(6):191–197. https://dx.doi.org/10.1002/jgf2.201

24. Williams D.J., Zhu Y., Grijalva C.G., et al. Predicting severe pneumonia outcomes in children. Pediatrics. 2016;138(4):e20161019. https://dx.doi.org/10.1542/peds.2016-1019

25. Adar A., Goldbart A.D., Burrack N., et al. C-Reactive Protein Is Associated with Severity in Hospitalized Children with Respiratory Syncytial Virus Bronchiolitis. Isr Med Assoc J. 2025;27(3):165–171.

26. Hoshina T., Nanishi E., Kanno S., et al. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis. J Infect Chemother. 2014;20(10):616-620. https://dx.doi.org/10.1016/j.jiac.2014.06.003

27. Berg A.S., Inchley C.S., Fjaerli H.O., et al. Clinical features and inflammatory markers in pediatric pneumonia: a prospective study. Eur J Pediatr. 2017;176(5):629-638. https://dx.doi.org/10.1007/s00431-017-2887-y

28. Thomas J., Pociute A., Kevalas R., et al. Blood biomarkers differentiating viral versus bacterial pneumonia aetiology: a literature review. Ital J Pediatr. 2020;46(1):4. https://dx.doi.org/10.1186/s13052-020-0770-3

29. Bennet R., Hamrin J., Wirgart B.Z., et al. Influenza epidemiology among hospitalized children in Stockholm, Sweden 1998-2014. Vaccine. 2016;34(28):3298-3302. https://dx.doi.org/10.1016/j.vaccine.2016.04.082

30. Prat C., Domínguez J., Rodrigo C., et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection. Pediatr Infect Dis J. 2003;22(11):963-968. https://dx.doi.org/10.1097/01.inf.0000095197.72976.4f

31. Jiang Y., Wang W., Zhang Z., et al. Serum amyloid a, C-reactive protein, and procalcitonin levels in children with Mycoplasma pneumoniae infection. J Clin Lab Anal. 2022;36(3):e24265. https://dx.doi.org/10.1002/jcla.24265

32. Liu F., Chen L., Wang M.Y., et al. Exploring high-risk factors for the prediction of severe mycoplasma pneumonia in children. Transl Pediatr. 2024;13(11):2003-2011. https://dx.doi.org/10.21037/tp-24-293

33. Ling Y., Zhang T., Guo W., et al. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infect Dis. 2020;20(1):534. https://dx.doi.org/10.1186/s12879-020-05270-6

34. Baumann P., Baer G., Bonhoeffer J., et al. Procalcitonin for Diagnostics and Treatment Decisions in Pediatric Lower Respiratory Tract Infections. Front Pediatr. 2017;5:183. https://dx.doi.org/10.3389/fped.2017.00183

35. Becker L.A., Hom J., Villasis-Keever M., van der Wouden J.C. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev. 2011;(7):CD001726. https://dx.doi.org/10.1002/14651858.CD001726.pub4 Update in: Cochrane Database Syst Rev. 2015 Sep 03;(9):CD001726. https://dx.doi.org/10.1002/14651858.CD001726.pub5

36. Backman K., Helminen M., Kekäläinen E., et al. Working group summary of the 2023 full update of the Finnish national guidelines for paediatric lower respiratory tract infections. Acta Paediatr. 2025;114(2):248-257. https://dx.doi.org/10.1111/apa.17481

37. Williams S., Engels J., Ogrin S., et al. Reducing inappropriate antibiotic prescribing for acute uncomplicated bronchitis: a systemwide quality improvement project. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e222. https://dx.doi.org/10.1017/ash.2024.465

38. Шаталина С.И., Аксенова М.Б., Колосова Н.Г. и др. Комбинированные препараты в лечении кашля при острых респираторных инфекциях, протекающих с бронхиальной обструкцией. Фарматека. 2025:32(7):97–104.

39. Naz F., Raza A.B., Ijaz I., Kazi M.Y. Effectiveness of nebulized N-acetylcysteine solution in children with acute bronchiolitis. J Coll Physicians Surg Pak. 2014;24(6):408–411.

40. Benedetti F., Santus P. N-acetylcysteine in paediatrics: a review of efficacy, safety and dosing strategies in respiratory care. Drugs Context. 2025;14:2025-7-7. https://dx.doi.org/10.7573/dic.2025-7-7

41. Колосова Н.Г., Гребенева И.В., Денисова В.Д., Максимова Е.М. Место комбинированных препаратов в терапии острого бронхита у детей. Медицинский совет. 2020;(10):42–47.

42. Morgan J.R., Drainoni M-L., Christiansen C., Barlam T.F. Patient-provider race and sex concordance: New insights into antibiotic prescribing for acute bronchitis Journal of Health Disparities Research and Practice. 2017;10(4):67–76.

43. Walker P.J., Wilkes C., Duke T., Graham H.R.; ARI Review group. Can child pneumonia in low-resource settings be treated without antibiotics? A systematic review & meta-analysis. J Glob Health. 2022;12:10007. https://dx.doi.org/10.7189/jogh.12.10007

44. Карпов О.И., Рязанцев С.В., Тихомирова И.А. Путь повышения эффективности и переносимости антибиотикотерапии при синусите у детей. Детские инфекции. Диагностика и вакцины. 2006:5(3):52–56.

45. Зырянов С.К., Байбулатова Е.А. Использование новых лекарственных форм антибиотиков как путь повышения эффективности и безопасности антибактериальной терапии. Антибиотики и химиотерапия. 2019; 64(3–4):81–91.